Composition
Cap 5 mg/20 mg/100 mg/140 mg/180 mg/250 mg: Temozolomide 5 mg/20 mg/100 mg/140 mg/180 mg/250 mg.
Indications & Dosage
Newly diagnosed glioblastoma multiforme in adults (in combination with radiotherapy) and subsequently as monotherapy, Second-line treatment of malignant glioma in adults: Adults: 150-200 mg/m2/day for 5 days, repeat every 28 days (consult product literature).
Precautions
Hepatic & renal impairment, elderly, risk of Pneumocystis jirovecii pneumonia; consult product literature for monitoring and prevention
Pregnancy
Positive evidence of risk: Avoid
Lactation
Contraindicated. Discontinue breast-feeding
Side Effects
Alopecia, bone-marrow suppression, hyperuricaemia, nausea, oral mucositis, Peripheral oedema thromboembolism, tumourlysis syndrome, vomiting